tradingkey.logo
搜索

Phibro Animal Health Corp

PAHC
添加自选
34.370USD
-1.780-4.92%
收盘 05/15, 16:00美东报价延迟15分钟
1.39B总市值
14.63市盈率 TTM

Phibro Animal Health Corp

34.370
-1.780-4.92%

关于 Phibro Animal Health Corp 公司

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Phibro Animal Health Corp简介

公司代码PAHC
公司名称Phibro Animal Health Corp
上市日期Apr 11, 2014
CEOBendheim (Jack C)
员工数量2475
证券类型Ordinary Share
年结日Apr 11
公司地址Glenpointe Centre East, 3Rd Floor
城市TEANECK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07666
电话12013297300
网址https://www.pahc.com/
公司代码PAHC
上市日期Apr 11, 2014
CEOBendheim (Jack C)

Phibro Animal Health Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+3.98%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%
地区USD
名称
营收
占比
United States
221.76M
59.31%
Latin America and Canada
87.60M
23.43%
Europe & Middle East & Africa
44.78M
11.98%
Asia Pacific
19.77M
5.29%
业务
地区
业务USD
名称
营收
占比
MFAs and Other
202.11M
54.05%
Nutritional specialties
50.23M
13.43%
Vaccines
37.64M
10.07%

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
其他
71.44%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.89%
State Street Investment Management (US)
4.47%
Vanguard Capital Management, LLC
4.23%
Millennium Management LLC
3.04%
Acadian Asset Management LLC
2.93%
其他
71.44%
股东类型
持股股东
占比
Investment Advisor
53.06%
Investment Advisor/Hedge Fund
28.56%
Hedge Fund
10.67%
Research Firm
2.76%
Pension Fund
1.42%
Bank and Trust
0.69%
Individual Investor
0.59%
Corporation
0.46%
Family Office
0.39%
其他
1.42%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
474
22.03M
104.57%
-645.50K
2025Q4
432
20.14M
97.68%
-3.60M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
2.93M
14.19%
+6.03K
+0.21%
Dec 31, 2025
State Street Investment Management (US)
942.28K
4.57%
+48.24K
+5.40%
Dec 31, 2025
Millennium Management LLC
641.31K
3.11%
+626.49K
+4227.06%
Dec 31, 2025
Acadian Asset Management LLC
702.65K
3.41%
-83.17K
-10.58%
Dec 31, 2025
Geode Capital Management, L.L.C.
569.11K
2.76%
+21.95K
+4.01%
Dec 31, 2025
Renaissance Technologies LLC
545.30K
2.64%
-9.90K
-1.78%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
492.33K
2.39%
+6.83K
+1.41%
Dec 31, 2025
Fidelity Management & Research Company LLC
477.06K
2.31%
+63.44K
+15.34%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
占比2.49%
State Street SPDR S&P Pharmaceuticals ETF
占比1.19%
Innovator IBD 50 Fund ETF
占比1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
占比1.06%
Inspire Fidelis Multi Factor ETF
占比1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.02%
Lattice Hartford Multifactor Small Cap ETF
占比0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
占比0.76%
Invesco NASDAQ Future Gen 200 ETF
占比0.61%
Invesco S&P SmallCap Health Care ETF
占比0.52%

分红派息

近5年累计派现 97.20M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
May 05, 2026
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Jun 24, 2026 going ex on Jun 03, 2026
Jun 03, 2026
Jun 24, 2026
Jun 03, 2026
Feb 03, 2026
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 25, 2026 going ex on Mar 04, 2026
Mar 04, 2026
Mar 25, 2026
Mar 04, 2026
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
查看更多

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI